Table 2 Overall characteristics of clinical Lactobacillus isolates, commercial probiotics and reference strains.
Isolate | Growth rate | Culture pH | Adhesion | Hydrogen peroxide | L-lactate | D-lactate | Inflammatory response | Sum |
|---|---|---|---|---|---|---|---|---|
LJ 5 | 3 | 2 | 3 | 2 | 3 | 2 | 3 | 18 |
LM 2 | 2 | 1 | 3 | 3 | 2 | 1 | 3 | 15 |
LJ 4 | 1 | 3 | 2 | 3 | 3 | 0 | 3 | 15 |
LJ 1 | 3 | 3 | 3 | 3 | 0 | 2 | 0 | 14 |
LC 7 | 3 | 3 | 1 | 3 | 0 | 2 | 1 | 13 |
LA capsule | 2 | 3 | 1 | 2 | 2 | 2 | 1 | 13 |
LC 6 | 3 | 3 | 2 | 1 | 2 | 0 | 2 | 13 |
LV 3 | 3 | 0 | 1 | 0 | 2 | 3 | 3 | 12 |
LJ 6* | 0 | 2 | 0 | 3 | 3 | 3 | 1 | 12 |
LA tablet | 3 | 2 | 3 | 1 | 0 | 3 | 0 | 12 |
LV 2 | 2 | 0 | 2 | 0 | 2 | 3 | 2 | 11 |
LG 2* | 0 | 2 | 2 | 2 | 3 | 2 | 0 | 11 |
LJ 3 | 0 | 2 | 0 | 2 | 3 | 3 | 1 | 11 |
LJ 2 | 1 | 0 | 3 | 2 | 3 | 1 | 0 | 10 |
LM 4 | 2 | 1 | 2 | 3 | 0 | 2 | 0 | 10 |
LV 5 | 1 | 0 | 1 | 1 | 3 | 3 | 0 | 9 |
LM 1 | 1 | 1 | 2 | 2 | 0 | 2 | 1 | 9 |
LC 4 | 1 | 2 | 3 | 0 | 0 | 1 | 2 | 9 |
LC 1 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 9 |
LCR | 3 | 3 | 1 | 0 | 0 | 1 | 1 | 9 |
LM 3 | 1 | 1 | 1 | 3 | 0 | 0 | 2 | 8 |
LC 5 | 0 | 1 | 2 | 2 | 0 | 0 | 3 | 8 |
LC 8* | 2 | 2 | 0 | 1 | 0 | 1 | 2 | 8 |
LC 3 | 0 | 2 | 2 | 0 | 2 | 1 | 1 | 8 |
LV 4 | 1 | 0 | 1 | 0 | 0 | 3 | 2 | 7 |
LV 1 | 1 | 1 | 0 | 0 | 2 | 1 | 2 | 7 |
LC 2 | 2 | 0 | 0 | 0 | 0 | 2 | 2 | 6 |
LV 6 | 0 | 0 | 1 | 1 | 0 | 0 | 3 | 5 |
LG 1 | 0 | 1 | 0 | 2 | 0 | 0 | 2 | 5 |
LC 9* | 2 | 1 | 0 | 0 | 0 | 1 | 1 | 5 |
